Scheffler v. Secretary of Health and Human Services ( 2023 )

In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 19-260V
(not to be published)
************************* *
*
SCOTT SCHEFFLER, *
*
* Filed: October 24, 2023
Petitioner, *
*
v. *
*
*
SECRETARY OF HEALTH AND *
HUMAN SERVICES, *
*
*
Respondent. *
*
************************* *
Anne Carrion Toale, Maglio Christopher and Toale, Sarasota, FL, for Petitioner
Austin Joel Egan, U.S. Department of Justice, Washington, DC, for Respondent
DECISION ON JOINT STIPULATION1
On February 15, 2019, Scott Scheffler (“Petitioner”) filed a petition, seeking compensation
under the National Vaccine Injury Compensation Program (“the Vaccine Program”). 2 Pet., ECF
No. 1. Petitioner alleges he suffered from Henoch Schoenlein purpura and its sequelae as a result
of the Twinrix hepatitis A and B (“Twinrix”) vaccine he received on or about May 2, 2018. See
Stipulation ¶ 2, 4, dated October 24, 2023 (ECF No. 60); see also Petition.
Respondent denies “that petitioner suffered from Henoch Schoenlein purpura or any other
vascular or cardiac injury as a result of either Twinrix vaccine, and denies that either Twinrix
1
Because this Decision contains a reasoned explanation for the action in this case, it must be made publicly
accessible and will be posted on the United States Court of Federal Claims' website, and/or
at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government
Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Decision will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that
the identified material fits within this definition, I will redact such material from public access.
2
The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter
“Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the
pertinent subparagraph of 42 U.S.C. § 300aa.
vaccine caused him any other injury or his current condition.” See Stipulation ¶ 6. Nonetheless,
both parties, while maintaining their above-stated positions, agreed in a stipulation filed October
24, 2023, that the issues before them can be settled and that a decision should be entered awarding
Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth
therein.
The stipulation awards:
a lump sum of $77,500.00 in the form of a check payable to petitioner.
Stipulation ¶ 8. This award represents compensation for all damages that would be available under
42 U.S.C. § 300aa-15(a).
I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
the Court is directed to enter judgment herewith. 3
IT IS SO ORDERED.
s/ Katherine E. Oler
Katherine E. Oler
Special Master
3
Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice
renouncing their right to seek review.